Stay updated on Nusinersen Safety in SMA Clinical Trial
Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.

Latest updates to the Nusinersen Safety in SMA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.5.0 deployed; previously v3.4.3. The update does not modify study content or user actions.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision updated to v3.4.3. Previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe page adds Revision: v3.4.2 and removes Revision: v3.4.1, along with deletion of a government funding lapse notice; these are administrative updates to the site and do not modify the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedA site-wide notice informs users about a lapse in government funding and NIH operations status. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check58 days agoChange DetectedThis update adds: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, and removes Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check72 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3'. There are no observed changes to core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.